Centiva Capital, LP Prestige Consumer Healthcare Inc. Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$56.28 - $63.76 $29,321 - $33,218	-521 Reduced 9.79%	4,801 $285,000
Q1 2023 May 15, 2023	BUY	$58.41 - $67.05 $67,054 - $76,973	1,148 Added 27.5%	5,322 $333,000
Q4 2022 Feb 14, 2023	BUY	$49.75 - $63.89 $8,308 - $10,669	167 Added 4.17%	4,174 $261,000
Q3 2022 Nov 14, 2022	BUY	$48.72 - $61.12 $195,221 - $244,907	4,007 New	4,007 $200,000
Q4 2021 Feb 14, 2022	SELL	$55.41 - $63.3 $213,439 - $243,831	-3,852 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$51.0 - $60.54 $196,452 - $233,200	3,852 New	3,852 $216,000

337

50.2M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.68B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.